ANDA Filers Lose Again On Eliquis Patents With Monopoly Set For 2028
HEC’s Sunshine Lake Pharma, Sigmapharm and Unichem Fail On Appeal
ANDA filers that went to trial over Bristol Myers Squibb and Pfizer’s Eliquis blockbuster face a seven-year wait to launch their generic products after the US Court of Appeals for the Federal Circuit upheld a lower court decision.
